Name: UMIN ID:
Unique ID issued by UMIN | UMIN000022999 |
---|---|
Receipt number | R000026509 |
Scientific Title | anti-albuminuric effect of 1ow-dose spironolactone in patients with diabetic nephropathy |
Date of disclosure of the study information | 2016/07/03 |
Last modified on | 2023/05/09 18:32:16 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/07/03 21:13:10 | ||
2 | Update | 2017/07/17 19:31:51 | Key exclusion criteria Key exclusion criteria |
|
3 | Update | 2017/07/17 19:42:19 | Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name Address Address TEL Institute Department Organization Division |
|
4 | Update | 2018/08/19 18:52:22 | UMIN ID1 |
|
5 | Update | 2018/12/12 16:12:34 | Last name of lead principal investigator Last name of lead principal investigator Last name of contact person Last name of contact person Name of person sending information Name of person sending information |
|
6 | Update | 2019/01/06 00:44:56 | Recruitment status |
|
7 | Update | 2021/07/07 17:57:07 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of person sending information Organization Organization Address Address Tel |
|
8 | Update | 2021/07/07 18:03:13 | Date of IRB Last follow-up date |
|
9 | Update | 2023/05/09 11:28:24 | Recruitment status |
|
10 | Update | 2023/05/09 18:32:16 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |